Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	5/12/2006 2:27:00 AM
	of 3044

SOUTH SAN FRANCISCO, Calif., May 11 /PRNewswire-FirstCall/ -- Genentech, Inc. (NYSE: DNA) today announced two vice president appointments: Michael P. Miller to vice president, Sales and Marketing, HER Family*; and David Schenkein, M.D., to vice president, Clinical Hematology/Oncology. Too bad to see Schenkein leave. He always came through as a very competent person. Which he evidently also was, considering his new position. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next